Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Xie Zhiqi¹,Ikegami Tamami¹,Ago Yukio²³,Okada Naoki¹,Tachibana Masashi¹³^ORCID

Affiliation:

1. Project for Vaccine and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan

2. Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan

3. Global Center for Medical Engineering and Informatics, Osaka University, Osaka, Japan

Funder

Japan Society for the Promotion of Science

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1734268

Reference40 articles.

1. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

2. The future of immune checkpoint therapy

3. Cancer immunotherapy comes of age

4. Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

5. Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies;Journal of Cancer Research and Clinical Oncology;2024-05-08

2. Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies;Drug Resistance Updates;2024-05

3. Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy;Asian Journal of Pharmaceutical Sciences;2024-04

4. Chidamide improves gefitinib treatment outcomes in NSCLC by attenuating recruitment and immunosuppressive function of myeloid-derived suppressor cells;Biomedicine & Pharmacotherapy;2024-04

5. Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells;Cytokine & Growth Factor Reviews;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3